Nucs AI was featured as a sponsor for ProsTIC Theranostics 2026 in Melbourne.
Public source
Publisher name
Public post
ProsTIC Theranostics 2026 closed in Melbourne last week. Radioligand therapy is established, and every treatment decision still happens one patient at a time. The meetin…
Company
Nucs AI
Detection, Prediction, and Monitoring for Theranostics and Molecular Imaging.
- Industry
- Hospitals and Health Care
- Location
- New York, US
- Company size
- 11–50 employees
About Nucs AI
Nucs AI is a clinical AI platform for theranostics and molecular imaging. Our software supports physicians across the full care pathway: detection, prediction, and monitoring for theranostics and molecular imaging. With Nucs AI, physicians can detect disease earlier, identify which patients are most likely to respond to treatment before it begins, and track how disease evolves over time. Our platform turns complex imaging data into clear, evidence-based insights that support more confident clinical decisions at every stage of care. By combining clinical rigor with applied AI, Nucs AI is helping shape how theranostic care is delivered. Join us in shaping the future of healthcare and improving outcomes for patients worldwide.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Qureight
Qureight is presenting nine abstracts at the 2026 ERS Congress in Barcelona focusing on AI-powered quantitative imaging biomarkers for respiratory clinical trials.
Presence & Recognition
Aiforia Technologies
Aiforia Technologies is exhibiting at the ECP2026 conference featuring scientific presentations showcasing the Aiforia Platform.
Presence & Recognition
Ultromics
Ultromics is attending the ASNC2026 conference in Las Vegas to support the meeting and connect with attendees.
Presence & Recognition
RealActivity
RealActivity featured Paul Swider teaching AI risk management for pharmacy leaders at the 2026 Hospital Pharmacy Buyer Conference in Orlando.
Presence & Recognition
SyntheticMR